Indaptus Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview

Indaptus Therapeutics

23/02/2024 13:39

* Indaptus Therapeutics Inc  INDP.OQ   INDP.O  is expected
to report resultson February 26 (estimated) for the period
ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Indaptus Therapeutics
Inc is
for a loss of 54 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Indaptus
Therapeutics Inc is $10.00​, above​ its last closing price
of $1.91. ​​​

This summary was machine generated February 23 at 13:39 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)